Susan Khan

494 total citations
14 papers, 412 citations indexed

About

Susan Khan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Susan Khan has authored 14 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Organic Chemistry. Recurrent topics in Susan Khan's work include Melanoma and MAPK Pathways (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Nuclear Receptors and Signaling (2 papers). Susan Khan is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Nuclear Receptors and Signaling (2 papers). Susan Khan collaborates with scholars based in United States, Brazil and Canada. Susan Khan's co-authors include Michael D. Cameron, Philip V. LoGrasso, Douglas E. Vaughan, Linda A. Gleaves, Layton H. Smith, Khandaker Siddiquee, Thomas Schröter, Yan Yin, Wayne Grant and Jennifer Pocas and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecular Pharmacology and Neuropharmacology.

In The Last Decade

Susan Khan

14 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Khan United States 11 199 105 102 67 66 14 412
Alessio Moriconi Italy 11 147 0.7× 45 0.4× 68 0.7× 59 0.9× 48 0.7× 21 465
Paul DaSilva‐Jardine United States 12 270 1.4× 91 0.9× 182 1.8× 94 1.4× 64 1.0× 16 659
James Wakefield United States 12 227 1.1× 32 0.3× 89 0.9× 47 0.7× 79 1.2× 26 626
Jun Yuan China 14 336 1.7× 91 0.9× 32 0.3× 79 1.2× 21 0.3× 28 654
Hiromi Sugimoto Japan 12 185 0.9× 65 0.6× 130 1.3× 72 1.1× 54 0.8× 23 525
Bayan Aljabari United States 12 81 0.4× 126 1.2× 44 0.4× 295 4.4× 21 0.3× 15 923
Nigel Beaton Switzerland 10 239 1.2× 20 0.2× 28 0.3× 30 0.4× 68 1.0× 17 517
Michał Załuski Poland 8 129 0.6× 41 0.4× 63 0.6× 43 0.6× 15 0.2× 12 295
Richard G. Conway United States 11 223 1.1× 74 0.7× 24 0.2× 82 1.2× 40 0.6× 24 458
Toshikatsu Nakabayashi Japan 13 281 1.4× 19 0.2× 46 0.5× 30 0.4× 54 0.8× 37 461

Countries citing papers authored by Susan Khan

Since Specialization
Citations

This map shows the geographic impact of Susan Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Khan more than expected).

Fields of papers citing papers by Susan Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Khan. The network helps show where Susan Khan may publish in the future.

Co-authorship network of co-authors of Susan Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Khan. A scholar is included among the top collaborators of Susan Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Khan. Susan Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lin, Li, et al.. (2023). Basolateral amygdala corticotropin releasing factor receptor 2 interacts with nonmuscle myosin II to destabilize memory in males. Neurobiology of Learning and Memory. 206. 107865–107865. 3 indexed citations
2.
Tóth, Katalin, et al.. (2023). Addressing the oxamniquine in vitro-in vivo paradox to facilitate a new generation of anti-schistosome treatments. International Journal for Parasitology Drugs and Drug Resistance. 21. 65–73. 3 indexed citations
3.
Pryce, Kerri D., Hye Jin Kang, Farhana Sakloth, et al.. (2021). A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects. Neuropharmacology. 195. 108673–108673. 22 indexed citations
4.
Higginson, Cody J., et al.. (2016). Albumin-Oxanorbornadiene Conjugates Formed ex Vivo for the Extended Circulation of Hydrophilic Cargo. ACS Chemical Biology. 11(8). 2320–2327. 16 indexed citations
5.
Chang, Mi Ra, Yuanjun He, Tanya Khan, et al.. (2015). Antiobesity Effect of a Small Molecule Repressor of RORγ. Molecular Pharmacology. 88(1). 48–56. 33 indexed citations
6.
Asteian, Alice, Anne‐Laure Blayo, Yuanjun He, et al.. (2015). Design, Synthesis, and Biological Evaluation of Indole Biphenylcarboxylic Acids as PPARγ Antagonists. ACS Medicinal Chemistry Letters. 6(9). 998–1003. 25 indexed citations
7.
Calvet, Cláudia M., Débora Vieira, Jun Yong Choi, et al.. (2014). 4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruziDrug Leads with Improved Pharmacokinetic Profile and in Vivo Potency. Journal of Medicinal Chemistry. 57(16). 6989–7005. 38 indexed citations
8.
Yin, Yan, Lin Li, Claudia Ruiz, et al.. (2013). Synthesis and Biological Evaluation of Urea Derivatives as Highly Potent and Selective Rho Kinase Inhibitors. Journal of Medicinal Chemistry. 56(9). 3568–3581. 34 indexed citations
9.
He, Yuanjun, Theodore M. Kamenecka, Youseung Shin, et al.. (2011). Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) Inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(6). 1719–1723. 22 indexed citations
10.
Siddiquee, Khandaker, et al.. (2011). Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production. Journal of Hypertension. 29(4). 724–731. 85 indexed citations
11.
Crocker, Candice E., Susan Khan, Michael D. Cameron, et al.. (2011). JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease. ACS Chemical Neuroscience. 2(4). 207–212. 40 indexed citations
12.
Yin, Yan, Michael D. Cameron, Lin Li, et al.. (2010). Discovery of Potent and Selective Urea-Based ROCK Inhibitors and Their Effects on Intraocular Pressure in Rats. ACS Medicinal Chemistry Letters. 1(4). 175–179. 39 indexed citations
13.
Fang, X. M., Yan Yin, Yen‐Ting Chen, et al.. (2010). Tetrahydroisoquinoline Derivatives As Highly Selective and Potent Rho Kinase Inhibitors. Journal of Medicinal Chemistry. 53(15). 5727–5737. 51 indexed citations
14.
Choudhry, Mashkoor A., et al.. (1999). PROLIFERATIVE AND FUNCTIONAL DISTURBANCES IN PERIPHERAL AND MUCOSAL T CELLS FOLLOWING BURN AND BURN-INFECTION. Shock. 11(Supplement). 82–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026